EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TCIRG1 as a Novel Prognostic Biomarker Triggering Immune Infiltration in Renal Clear Cell Carcinoma: An Integrative Study of Single‐Cell and Bulk Data

Wei Ye iD, Honghao Yang, Xincheng Yi, Shaoyi Zhang, Siyu Wang, Zongming Jia iD, Jin Zang iD

Human Mutation · 2025

DOI: 10.1155/humu/1839494 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Mutation, 2025. Verfasst von Wei Ye und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Carcinoma, Renal Cell, Biomarkers, Tumor, Kidney Neoplasms. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Tumor microenvironment (TME) is a significant factor regulating the malignant phenotype and drug resistance of kidney renal clear cell carcinoma (KIRC). The identification of biomarker signatures mediating immune infiltration in TME is of significance for prognostic assessment and personalized therapy of KIRC.

Methods

The gene set associated with immune cell populations in KIRC TME was extracted from the single‐cell dataset GSE139555 using high‐dimensional weighted coexpression network analysis (hdWGCNA). The bulk data from TCGA‐KIRC were integrated to screen significant signatures in KIRC prognosis through Cox regression, and a combination of 101 machine learning algorithms was compared to prioritize feature genes for the construction of a novel prognostic model. Finally, LightGBM and XGBoost algorithms identified TCIRG1 as a key model feature and a novel biomarker in KIRC for experimental characterization using western blot, immunohistochemistry, multiple immunofluorescence (mIHC), subcutaneous tumor formation in nude mice, and Transwell assays.

Results

Single‐cell data showed that the monocyte population varied most significantly in KIRC samples, and 150 candidate genes from monocytes were identified based on hdWGCNA. By integrating bulk TCGA‐KIRC data and Cox regression, 15 prognosis‐related genes were extracted as candidates for machine learning–powered training using 101 algorithm combinations, and nine genes were prioritized as feature variables to establish a prognostic model with good predictive performance on the overall survival of KIRC patients. Finally, TCIRG1 was identified as a novel biomarker signature from the prognostic model, and ultimately, by combining LightGBM and XGBoost algorithms, TCIRG1 was identified as a key characteristic signal for experimental validation and functional studies. Immunohistochemistry, cellular, and animal experiments showed that TCIRG1 expression was significantly elevated in KIRC samples, and its high expression was closely associated with adverse clinicopathological features. mIHC results demonstrated a significant positive correlation between TCIRG1 expression and immune cell infiltration in the KIRC TME, particularly with Treg cells.

Conclusions

TCIRG1 was identified and validated as a novel prognostic biomarker triggering immune infiltration in KIRC. The mechanisms and translational prospects of TCIRG1 in KIRC management will be explored in future work.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Renal CellBiomarkers, TumorKidney NeoplasmsHumansPrognosisTumor MicroenvironmentAnimalsSingle-Cell AnalysisMiceGene Expression Regulation, NeoplasticFemale

Stichwörter der Autor:innen

TCIRG1immune infiltrationkidney renal clear cell carcinomaprognosistranslational biomedical informatics

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.
  • Department of Urology, Guanyun People's Hospital, Lianyungang, Jiangsu, China.

ORCID-Profile: Wei Ye, Zongming Jia, Jin Zang

Zitieren

APA

Ye, W., Yang, H., Yi, X., Zhang, S., Wang, S., Jia, Z., & Zang, J. (2025). TCIRG1 as a Novel Prognostic Biomarker Triggering Immune Infiltration in Renal Clear Cell Carcinoma: An Integrative Study of Single‐Cell and Bulk Data. Human Mutation. https://doi.org/10.1155/humu/1839494

Vancouver

Ye W, Yang H, Yi X, Zhang S, Wang S, Jia Z, et al. TCIRG1 as a Novel Prognostic Biomarker Triggering Immune Infiltration in Renal Clear Cell Carcinoma: An Integrative Study of Single‐Cell and Bulk Data. Human Mutation. 2025. doi:10.1155/humu/1839494

BibTeX
@article{Ye2025,
  author = {Ye, Wei and Yang, Honghao and Yi, Xincheng and Zhang, Shaoyi and Wang, Siyu and Jia, Zongming and Zang, Jin},
  title = {TCIRG1 as a Novel Prognostic Biomarker Triggering Immune Infiltration in Renal Clear Cell Carcinoma: An Integrative Study of Single‐Cell and Bulk Data},
  journal = {Human Mutation},
  year = {2025},
  doi = {10.1155/humu/1839494}
}
Kostenlos starten →